BLISTEX DCT
Google image searchProduct monograph
Active ingredients
octinoxate, 7.3 %
oxybenzone, 4.5 %
menthol, 0.6 %
phenol, 0.48 %
camphor, 0.38 %
DIN: 02157292
Dosage form(s): OINTMENT
Route(s) of administration: TOPICAL
Schedule: OTC
Company: BLISTEX CORPORATION
Date: 13-FEB-2014
ATC:
- D02 — EMOLLIENTS AND PROTECTIVES (ATC, ATC/DDD, )
- D02B — PROTECTIVES AGAINST UV-RADIATION (ATC, ATC/DDD)
- D02BA — Protectives against UV-radiation for topical use (ATC, ATC/DDD)
- D02BA30 — COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION (ATC/DDD)
Pharmaceutical standard: MFR
